Skip to main content
Clinical Trials/NCT01180010
NCT01180010
Completed
Not Applicable

Low-Dose Chest CT for Lung Cancer Screening in Survivors of Hodgkin's Disease

University Health Network, Toronto1 site in 1 country31 target enrollmentAugust 2010

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Hodgkin's Lymphoma
Sponsor
University Health Network, Toronto
Enrollment
31
Locations
1
Primary Endpoint
Lung cancer detection rate using chest CT screening in patients at increased risk of lung cancer after Hodgkin's disease therapy.
Status
Completed
Last Updated
9 years ago

Overview

Brief Summary

This research study is being done because patients with a history of chest radiation treatment for Hodgkin's disease have been shown to be at increased risk for developing lung cancer a number of years out from treatment. The risk appears to be further increased among patients with a smoking history. In this study, the CT scans will be read and interpreted by the study radiologist, and the results recorded in a consistent manner. Depending on the findings of the initial CT scan, we will then either repeat the scan in 1 year, or if indicated, send you for further scans or a biopsy. The information collected in this study will help researchers and clinicians in providing more concrete recommendations and screening guidelines for future survivors of Hodgkin's disease who have had similar exposures to radiation and/or chemotherapy and smoking.

Registry
clinicaltrials.gov
Start Date
August 2010
End Date
September 2015
Last Updated
9 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • 5 years or longer from initial Hodgkin's disease diagnosis
  • Current age 18 or older
  • Received mediastinal irradiation and/or alkylating-agent based chemotherapy
  • Smoking history of 10-pack years or more, or current smoker

Exclusion Criteria

  • Patients with a history of lung cancer
  • Patients currently receiving treatment for another cancer diagnosis (patients with another cancer, but currently disease-free and not receiving treatment are eligible)
  • Patients with known diagnosis of any metastatic cancer
  • Pregnant women. Female patients must: be at least one year post-menopausal, have had a hysterectomy, or have a serum pregnancy test to confirm that they are not pregnant. These measures must be taken in order to avoid doing a CT scan of a pregnant woman.

Outcomes

Primary Outcomes

Lung cancer detection rate using chest CT screening in patients at increased risk of lung cancer after Hodgkin's disease therapy.

Time Frame: 5 years

False-positive rates of using chest CT for lung cancer screening in this population.

Time Frame: 5 years

Secondary Outcomes

  • The stage distribution, clinical characteristics and pathologic features of the detected lung cancer(5 years)
  • The treatment and treatment outcome of lung cancer after Hodgkin's disease in a cohort of patients undergoing routine chest CT screening(5 years)

Study Sites (1)

Loading locations...

Similar Trials